Shanghai AccuTarget Medical

AccuTarget Medical is a Shanghai-based medical technology company focused on the research, development, and commercialization of neuro-interventional medical devices. Established in 2017, the company provides a comprehensive suite of products for treating cerebrovascular diseases, including flow diverters, embolic coils, and access catheters. Their flagship products, such as the L-FLOW flow diverter and L-COIL embolic system, are designed to address the high clinical demand for stroke treatment in China. AccuTarget aims to provide high-quality, domestically produced alternatives to international neurovascular brands through continuous innovation in precision manufacturing. The company has successfully raised significant venture capital from prominent investors like Sequoia China to expand its R&D and manufacturing capabilities.